Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Phase 2 trial data (published in the New England Journal of Medicine, 2023) have demonstrated significant weight loss and improvements in glycaemic markers, but the complete safety profile including the precise risk of low blood sugar continues to be characterised
The pen delivery system makes dosing simple, eliminating the need for manual syringe measurements
Many people dramatically reduce their calorie intake during the first few months of treatment
I am not one of those people
Success is about so much more than a number on a scale
US$ 21.99
US$ 27.89
US$ 22.94
US$ 26.73
US$ 20.13
US$ 27.75
